Home
/
AdaptHealth Corp.
/
Financials
/
Quarterly
AdaptHealth Corp. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that AdaptHealth Corp. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$820.31M
Nov 4, 2025
Q2
2025
Jun 30, 2025
$800.37M
Aug 5, 2025
Q1
2025
Mar 31, 2025
$777.88M
May 6, 2025
Q3
2025
Sep 30, 2024
$805.86M
Nov 4, 2025
Q2
2025
Jun 30, 2024
$805.98M
Aug 5, 2025
Q1
2025
Mar 31, 2024
$792.50M
May 6, 2025
Q3
2024
Sep 30, 2023
$804.03M
Nov 5, 2024
Q2
2024
Jun 30, 2023
$793.29M
Aug 6, 2024
Q1
2024
Mar 31, 2023
$744.63M
May 7, 2024
Q3
2023
Sep 30, 2022
$756.50M
Nov 7, 2023
Q2
2023
Jun 30, 2022
$727.61M
Aug 8, 2023
Q1
2023
Mar 31, 2022
$706.20M
May 9, 2023
Q3
2022
Sep 30, 2021
$653.29M
Nov 8, 2022
Q2
2022
Jun 30, 2021
$617.02M
Aug 9, 2022
Q1
2022
Mar 31, 2021
$482.12M
May 10, 2022
Q1
2021
Dec 31, 2020
$1.06B
May 10, 2021
Q3
2021
Sep 30, 2020
$284.41M
Nov 9, 2021
Q2
2021
Jun 30, 2020
$232.12M
Aug 6, 2021
Q1
2021
Mar 31, 2020
$191.44M
May 10, 2021
Q3
2020
Sep 30, 2019
$136.45M
Nov 6, 2020
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$24.51M
Nov 4, 2025
Q2
2025
Jun 30, 2025
$14.67M
Aug 5, 2025
Q1
2025
Mar 31, 2025
($7.21M)
May 6, 2025
Q3
2025
Sep 30, 2024
$22.86M
Nov 4, 2025
Q2
2025
Jun 30, 2024
$19.44M
Aug 5, 2025
Q1
2025
Mar 31, 2024
($2.13M)
May 6, 2025
Q3
2024
Sep 30, 2023
($454.08M)
Nov 5, 2024
Q2
2024
Jun 30, 2023
$13.98M
Aug 6, 2024
Q1
2024
Mar 31, 2023
$15.71M
May 7, 2024
Q3
2023
Sep 30, 2022
$16.12M
Nov 7, 2023
Q2
2023
Jun 30, 2022
$14.03M
Aug 8, 2023
Q1
2023
Mar 31, 2022
$41.75M
May 9, 2023
Q3
2022
Sep 30, 2021
$58.09M
Nov 8, 2022
Q2
2022
Jun 30, 2021
$79.11M
Aug 9, 2022
Q1
2022
Mar 31, 2021
($3.97M)
May 10, 2022
Q3
2021
Sep 30, 2020
($51.04M)
Nov 9, 2021
Q2
2021
Jun 30, 2020
$4.47M
Aug 6, 2021
Q1
2021
Mar 31, 2020
($34.55M)
May 10, 2021
Q3
2020
Sep 30, 2019
($3.69M)
Nov 6, 2020
Q2
2020
Jun 30, 2019
($2.08M)
Aug 7, 2020
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$61.73M
Nov 4, 2025
Q2
2025
Jun 30, 2025
$79.25M
Aug 5, 2025
Q1
2025
Mar 31, 2025
$23.17M
May 6, 2025
Q3
2025
Sep 30, 2024
$63.49M
Nov 4, 2025
Q2
2025
Jun 30, 2024
$52.05M
Aug 5, 2025
Q1
2025
Mar 31, 2024
$50.53M
May 6, 2025
Q3
2024
Sep 30, 2023
($461.04M)
Nov 5, 2024
Q2
2024
Jun 30, 2023
$54.26M
Aug 6, 2024
Q1
2024
Mar 31, 2023
$26.18M
May 7, 2024
Q3
2023
Sep 30, 2022
$52.95M
Nov 7, 2023
Q2
2023
Jun 30, 2022
$59.18M
Aug 8, 2023
Q1
2023
Mar 31, 2022
$51.55M
May 9, 2023
Q3
2022
Sep 30, 2021
$75.71M
Nov 8, 2022
Q2
2022
Jun 30, 2021
$65.41M
Aug 9, 2022
Q1
2022
Mar 31, 2021
$15.41M
May 10, 2022
Q3
2021
Sep 30, 2020
$13.26M
Nov 9, 2021
Q2
2021
Jun 30, 2020
$15.57M
Aug 6, 2021
Q1
2021
Mar 31, 2020
$8.22M
May 10, 2021
Q3
2020
Sep 30, 2019
$8.72M
Nov 6, 2020
Q2
2020
Jun 30, 2019
$14.91M
Aug 7, 2020